// App-Quantinova.ai

: Periostin Is a Novel Biomarker for Sarcoidosis

Researchers

Presenter

  • T. Isshiki

Principal Investigators

  • H. Matsuyama

  • H. Shimizu

  • T. Yamaguchi

  • J. Ono

  • S. Nunomura

  • K. Izuhara

  • S. Sakamoto

  • S. Homma

Medical Centers

  • Respiratory Medicine, Toho Universtiy, Tokyo, Japan,

  • Department of Respiratory Medicine, Shinjuku-Kaijo Bilding Clinic, Tokyo, Japan,

  • Shino-test Co.Ltd, Tokyo, Japan.

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

  • Asthma

  • Sarcoidosis

Biomarkers

  • Periostin

  • Interleukin-2

  • Soluble interleukin-2 receptor

Drug/Treatment

  • Angiotensin II

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved